Report forecasts the multiple myeloma market to reach $40.41B by 2033 (from $21.78B in 2024), driven by rising cases and therapy advances.
Looking For Market Distribution? Download the Media Kit
Report forecasts the multiple myeloma market to reach $40.41B by 2033 (from $21.78B in 2024), driven by rising cases and therapy advances.